Stay up to date on news, events, and other items of interest to our AN community.
Sponsor Post: Complex Case: Rare Cochlear Implantation After Previous NF2 Tumor Removal
This article was reposted with the permission of NYU Langone.
A recent cochlear implantation restored hearing in a patient left profoundly deaf by prior surgery and radiation treatment for neurofibromatosis type 2 (NF2) tumors. The successful cochlear implant (CI) application—rarely performed in such situations—challenges the long-held belief that the device is not a viable option for previously treated NF2 patients.
A recent article in the New York Times discusses falling, a topic that many acoustic neuroma patients contend with both before and after treatment. The article's title is a bit alarmist, but it contains good information about which medications can cause dizziness or drowsiness, what health issues can contribute to falls, and how to take steps to minimize your risk of falling.
Sponsor post: Weighing Intervention Timing and Type for Vestibular Schwannomas
This article was re-posted with permission from Vanderbilt University.
DECEMBER 07, 2018
New insights from the largest cohort study of tumor growth.
A significant percentage of vestibular schwannomas (VS), or acoustic neuromas, either grow relatively slowly or with little to no growth. Seeing a patient with an acoustic neuroma for the first time, it is difficult to know how long the tumor has been present, with variability from 5-25 years. Yet to date, there have been no definitive guidelines for weighing observation versus intervention.
Christina Liao, a high school sophomore from Hacienda Heights, whose uncle was diagnosed with acoustic neuroma in 2015, organized a fundraiser to benefit ANA in her uncle's honor. We are so thankful to Christina for her efforts! Read Christina's story: